Stay updated on Tirzepatide vs Insulin Degludec in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide vs Insulin Degludec in Type 2 Diabetes Clinical Trial page.

Latest updates to the Tirzepatide vs Insulin Degludec in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page added a new revision label Revision: v3.3.3 and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 entries from the footer/record history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedNew site revision entry v3.3.2 was added and the previous revision v3.2.0 was removed in the page history; this is a minor site-version update and does not change trial information.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved a general funding/operating status banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedOld and new screenshots show the same study record history content with no substantive changes to recruitment status, study status, or core details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference11%

- Check97 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to Tirzepatide vs Insulin Degludec in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide vs Insulin Degludec in Type 2 Diabetes Clinical Trial page.